Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection

Title
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
Authors
Keywords
-
Journal
ANTIVIRAL RESEARCH
Volume 172, Issue -, Pages 104637
Publisher
Elsevier BV
Online
2019-10-25
DOI
10.1016/j.antiviral.2019.104637

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More